We're building a radically more efficient pharma company.
Partner with TrialSpark
Our mission is to bring new treatments to patients faster and more efficiently.
TrialSpark’s tech-driven model is centered on radically more efficient drug development and value creation.
Acquire undervalued clinical stage drugs from Pharma and Biotech
Leverage our tech-driven development engine to uniquely develop drugs faster
Realize increased value inflection through asset sale or commercialization
Our therapeutic areas
Cardiometabolic
Rheumatology
Dermatology
CNS
TrialSpark's drug development model
Faster drug development through our proprietary tech-driven platform
- Time savings of 1-3+ years per drug program
- $1B+ sales advantage per drug program
- Scaled technology and automation compounds time saved across the portfolio
Structural advantage of in-house development that increases ROI
- Generate cost savings by leveraging our own trial services vs. paying third party
- Streamlined integrated drug development teams that support multiple programs at once
Best in class team, across drug selection, drug development, and tech
- Clinical & development expertise in cardiometabolic, dermatology, rheumatology, CNS
- 45+ drugs approved across the team
- Team composed of tech and biotech leaders
Select Partners
